Founded by patient advocates in 2017 as part of a larger organization, we commenced operations as our own free-standing public charity focused specifically on invasive lobular breast cancer (ILC) in December 2021. As our organization grows, we plan to make grants to fund research on the detection and treatment of ILC, and to continue supporting patient advocate involvement in ILC research and the need for greater awareness of this disease. We will continue to expand on our efforts to bring scientifically-vetted information about ILC to the public, clinicians and the scientific community through the efforts of our staff and patient advocate volunteers.